The Trump administration announced that it will delay the implementation of the BIDEN era rules, which restricts the scope of application of expensive bandages, known as skin substitutes on Friday.
It will be a policy It was delayed until 2026The company uses the loopholes of the Medicare rules to keep the price for new products. The New York Times reported that the company reported on Thursday that it is discounted to doctors who sell these bandages while discounted to doctors.
Medicare expenditures for large companies surged more than $ 2 billion in 2024 to $ 1.6 billion in 2022. Some experts say that bandage spending is one of the largest waste in Medicare’s history, an insurance program for the elderly.
The Super PAC of President Trump’s election campaign received $ 2 million from EXTREMITY CARE, a major seller of skin substitutes. Trump said he would blame the policy on social media twice, saying it would harm patients using products in diabetics.
Trump was in truth in March.
Extremity Care also criticized the plan, insisting that the plan would interfere with the supply chain and increase the costs of doctors and patients. The company said it did not immediately respond to the request for a new delay in the policy.
More than 120 skin substitutes are in the market. On average, they cost $ 5,089 per square inch, and the Times are the most expensive and the most expensive is more than $ 23,000.
The rules of the BIDEN era will limit the scope of media application to a small sub -set of products that are effective in randomly clinical trials. New policies are applied to patients using bandages on walking and leg wounds known as ulcers and can be caused by diabetes or circulatory defects.
Medicare is A Friday statement We will review the policy as part of the transition to a new administration. During that time, it said, “I think it’s important to maintain a patient’s approach to skin alternative products as evidence of high quality.”
Mass Coalition, a group that supports the skin replacement industry, said he was “happy” due to a delay and said the Trump administration would give time to evaluate policy changes. The group said, “We are expecting to cooperate with Medicare for the guarantee policy and payment reform that guarantees access to skin substitutes.
